Table 1 Clinico-pathological parameters of fifty locally advanced gastric cancer patients treated with/without prophylactic HIPEC
|  | Control group (n = 17) | Experimental group (n = 33) |
|---|---|---|
Age | 60 (50–86) | 61 (46–78) |
Sex, M/F | 14/3 | 27/6 |
KPS, 90/100 | 9/8 | 18/15 |
BMI | 21 (15–32) | 23 (16–34.5) |
Disease history, Yes/No | 11/6 | 13/20 |
Location, U/M/L | 5/3/9 | 14/4/15 |
Size, < 5 cm/≥5 cm | 13/4 | 16/17 |
Gastrectomy, Sub. /Tot. | 10/7 | 15/18 |
Histological diagnosis, Well/intermediately versus poorly/undifferentiated | 10/7 | 11/12 |
Lauren classification, Intestinal/diffuse/mixed | 6/6/4 | 13/6/12 |
Lymphovascular invasion, Yes/No | 6/11 | 18/15 |
Neurovascular invasion, Yes/No | 9/8 | 15/18 |
T stage, 1 ~ 3/4 | 12/5 | 22/11 |
N stage, 0/1 ~ 3 | 10/7 | 10/23 |
Ki67 IHC | 75% (50–99%) | 60% (10–90%) |
MSS/MSI | 10/2 | 26/2 |